Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Publication Title
The Journal of urology
Document Type
Article
Publication Date
4-26-2023
Keywords
california; santa monica; sjci; jwci; molecular imaging; positron-emission tomography; prostatic neoplasms
Abstract
PURPOSE: SPOTLIGHT (NCT04186845) evaluated diagnostic performance and safety of radiohybrid
MATERIALS AND METHODS: Men with prostate cancer recurrence underwent positron emission tomography/CT 50-70 minutes after intravenous administration of 296%±20% MBq
RESULTS: The overall
CONCLUSIONS:
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
Specialty/Research Institute
Diagnostic Imaging
DOI
10.1097/JU.0000000000003493
COinS
